Clin2
NCT07675811Possibly a fitRecruiting

Study of a new treatment for cat allergy related eye symptoms

Allergic Conjunctivitis

Part of Eyes & vision, Immune system & allergy clinical trials.

This trial tests an injectable treatment that may help manage eye allergy symptoms caused by cat allergies. It aims to see if the treatment is safe and effective for adults and children, and includes a controlled cat exposure challenge.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
570 people
Ages
8 years and older
Study type
Interventional

Who can take part

  • You are at least 8 years old.
  • You have tested positive for cat allergy through a skin prick test or a specific blood test (IgE) for cat dander and the Fel d 1 protein.
  • You have had eye symptoms (like itching or redness) during a controlled cat allergy exposure test, which the study will confirm.
  • You do not have severe lung disease (asthma) that required oral or injected steroids recently.
  • You do not have any other eye disease or major allergy that could interfere with the study results.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07309432Recruiting· Phase 3
Birch allergy shot study for eye symptoms

This trial tests a new antibody treatment for eye allergy symptoms caused by birch pollen. It may help if you have severe eye allergies during birch season.

Andover, Massachusetts
NCT06686472Recruiting· Phase 2
Testing TL-925 eye drops for allergic conjunctivitis

This trial tests an investigational eye drop called TL-925 to see if it can treat allergic conjunctivitis (eye allergies). If you have a history of eye allergies and a positive allergy skin test, you may be able to join.

Memphis, Tennessee
NCT07447869Recruiting· Early Phase 1
Lymph Node Exam in Cat Allergy Treatment Study

This study looks at lymph nodes in the neck to understand how the body responds to cat allergy treatments. It may help researchers improve allergy shots or other therapies for people with cat allergies.

Boston, Massachusetts
NCT00595491Recruiting· Phase 1
Study immune targets in cat and dust-mite allergic airway inflammation

This Phase 1 study looks at how the immune system drives allergic airway inflammation in people with allergic asthma, and compares them with allergic non-asthma and non-allergic healthy volunteers. The goal is to identify immune “signals” and cell “receptors” involved, which may guide better future treatments.

Boston, Massachusetts
NCT07710846Not yet recruiting
Cat and/or Birch Allergy Study

This study is looking for adults and children aged 5 and older who have allergies to cats (Part A) and/or birch pollen (Part B). The goal is to better understand these allergies. If you are allergic to cats, you must not currently live with a cat and must not have lived with one in the past year.

NCT05331170Recruiting· Phase 2
Re-training the nose to change how allergies behave

This Phase 2 study tests a “viral” treatment meant to reprogram the lining of your nose to reduce allergy-like immune responses. It is testing whether this approach is safe and can help people with cat allergy (with or without asthma) or compare against healthy people.

Galveston, Texas

Hear when a new Allergic Conjunctivitis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.